Gene: SMURF2
Official Full Name: SMAD specific E3 ubiquitin protein ligase 2provided by HGNC
Gene Summary: Enables SMAD binding activity; identical protein binding activity; and ubiquitin protein ligase activity. Involved in negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of trophoblast cell migration; and ubiquitin-dependent protein catabolic process. Located in nuclear speck. Part of ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11461 | SMURF2 Knockout cell line (HeLa) | Human | SMURF2 | 1:3~1:6 | Negative | Online Inquiry |
KO11462 | SMURF2 Knockout cell line (HCT 116) | Human | SMURF2 | 1:2~1:4 | Negative | Online Inquiry |
KO11463 | SMURF2 Knockout cell line (HEK293) | Human | SMURF2 | 1:3~1:6 | Negative | Online Inquiry |
KO11464 | SMURF2 Knockout cell line (A549) | Human | SMURF2 | 1:3~1:4 | Negative | Online Inquiry |
SMURF2 Gene Knockout Cell Lines are a genetically modified cell line tool that allows researchers to study the role of the SMURF2 gene in various biological processes. The SMURF2 gene encodes a protein that is known to act as an E3 ubiquitin ligase, playing a crucial role in regulating protein degradation and signaling pathways. By employing CRISPR-Cas9 technology, these knockout cell lines have been precisely engineered to lack functional SMURF2 protein, enabling detailed investigations into its contributions to cellular functions, including cytokine signaling, proliferation, and apoptosis.
The primary mechanism of action for the SMURF2 Gene Knockout Cell Lines revolves around loss-of-function analysis. Scientists can observe phenotypic changes, signaling pathway alterations, and impacts on cell cycle regulation that arise from the absence of SMURF2. This allows for a comprehensive understanding of how SMURF2 functions in various disease states, particularly in cancer biology, where its dysregulation is often implicated.
From a scientific standpoint, the SMURF2 Gene Knockout Cell Lines hold immense value in both research and clinical applications. Their utility extends to drug development projects testing compounds that target pathways modulated by SMURF2, as well as in basic research exploring cellular homeostasis and protein interactions. Additionally, these knockout models facilitate advancements in deciphering the molecular mechanisms underlying diseases, paving the way for novel therapeutic strategies.
Compared to traditional cell lines, the specificity of the SMURF2 knockout provides more reliable and reproducible results, addressing limitations associated with non-specific effects observed in standard experimental models. This specificity enhances the precision of experimental data, making it easier for researchers to draw significant conclusions and advance their work.
The value of the SMURF2 Gene Knockout Cell Lines lies in their capacity to provide insight into the multifaceted roles of the SMURF2 gene, offering researchers and clinicians a powerful tool in the study of its implications in various diseases. Our company delivers these high-quality cell lines, backed by extensive expertise in genetic engineering and cellular biology, ensuring that you receive not only a product but a partnership in advancing your scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.